Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment. | J Clin Med | 2022 | 36498469 | PubTator, text mining | PubMed |
| Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential. | Cancers (Basel) | 2022 | 36497266 | PubTator, text mining | PubMed |
| CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma. | Cancer Cell Int | 2022 | 36494696 | PubTator, text mining | PubMed |
| Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data. | BMC Med | 2022 | 36482464 | PubTator, text mining | PubMed |
| A genetically engineered, stem-cell-derived cellular vaccine. | Cell Rep Med | 2022 | 36480934 | PubTator, text mining | PubMed |
| Immunomodulatory role of metalloproteinase ADAM17 in tumor development. | Front Immunol | 2022 | 36466812 | PubTator, text mining | PubMed |
| Comprehensive Multiomic Analysis Identified TUBA1C as a Potential Prognostic Biological Marker of Immune-Related Therapy in Pan-Cancer. | Comput Math Methods Med | 2022 | 36466547 | PubTator, text mining | PubMed |
| Integrated analysis identifies the IL6/JAK/STAT signaling pathway and the estrogen response pathway associated with the pathogenesis of intracranial aneurysms. | Front Immunol | 2022 | 36451838 | PubTator, text mining | PubMed |
| The prospect of genetically engineering natural killer cells for cancer immunotherapy. | Biol Open | 2022 | 36445164 | PubTator, text mining | PubMed |
| The mechanisms on evasion of anti-tumor immune responses in gastric cancer. | Front Oncol | 2022 | 36439472 | PubTator, text mining | PubMed |
| Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn's Disease. | Front Immunol | 2022 | 36439157 | PubTator, text mining | PubMed |
| Remodeling tumor microenvironment with natural products to overcome drug resistance. | Front Immunol | 2022 | 36439106 | PubTator, text mining | PubMed |
| Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment. | BMC Cancer | 2022 | 36434591 | PubTator, text mining | PubMed |
| A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist. | Cells | 2022 | 36429011 | PubTator, text mining | PubMed |
| Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches. | Cells | 2022 | 36429001 | PubTator, text mining | PubMed |
| Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | 36428567 | PubTator, text mining | PubMed |
| The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis. | Bull Natl Res Cent | 2022 | 36415483 | PubTator, text mining | PubMed |
| A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators. | Front Genet | 2022 | 36406115 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36405728 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. | Front Immunol | 2022 | 36405712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=29